124 related articles for article (PubMed ID: 12796181)
1. Cytokeratin 19 fragment in patients with nonmalignant respiratory diseases.
Nakayama M; Satoh H; Ishikawa H; Fujiwara M; Kamma H; Ohtsuka M; Sekizawa K
Chest; 2003 Jun; 123(6):2001-6. PubMed ID: 12796181
[TBL] [Abstract][Full Text] [Related]
2. CYFRA 21-1 as a tumour marker for bronchogenic carcinoma.
Rapellino M; Niklinski J; Pecchio F; Furman M; Baldi S; Chyczewski L; Ruffini E; Chyczewska E
Eur Respir J; 1995 Mar; 8(3):407-10. PubMed ID: 7540561
[TBL] [Abstract][Full Text] [Related]
3. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of CA19-9 in patients with nonmalignant respiratory diseases.
Kodama T; Satoh H; Ishikawa H; Ohtsuka M
J Clin Lab Anal; 2007; 21(2):103-6. PubMed ID: 17385665
[TBL] [Abstract][Full Text] [Related]
5. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer.
Pujol JL; Grenier J; Daurès JP; Daver A; Pujol H; Michel FB
Cancer Res; 1993 Jan; 53(1):61-6. PubMed ID: 7677981
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trial.
Bombardieri E; Seregni E; Bogni A; Ardit S; Belloli S; Busetto A; Caniello B; Castelli M; Cianetti A; Correale M
Int J Biol Markers; 1994; 9(2):89-95. PubMed ID: 7523547
[TBL] [Abstract][Full Text] [Related]
7. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
Wieskopf B; Demangeat C; Purohit A; Stenger R; Gries P; Kreisman H; Quoix E
Chest; 1995 Jul; 108(1):163-9. PubMed ID: 7541742
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS.
Pujol JL; Grenier J; Parrat E; Lehmann M; Lafontaine T; Quantin X; Michel FB
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):725-33. PubMed ID: 8810612
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.
Maeda Y; Segawa Y; Takigawa N; Takata I; Fujimoto N
Intern Med; 1996 Oct; 35(10):764-71. PubMed ID: 8933183
[TBL] [Abstract][Full Text] [Related]
10. [Basic and clinical studies on serum cytokeratin 19 fragment assay using Centocor CYFRA 21-1 kit in patients with lung cancer].
Hamase A; Sugimoto Y; Maeda M; Kitani H; Fukuchi M
Kaku Igaku; 1994 Aug; 31(8):969-76. PubMed ID: 7523748
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer.
Niklinski J; Furman M; Chyczewska E; Chyczewski L; Rogowski F; Laudanski J
Eur Respir J; 1995 Feb; 8(2):291-4. PubMed ID: 7538933
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of serum assay of EIA-CYFRA 21-1 in lung cancer].
Satoh H; Yagyu H; Sumi M; Ishikawa H; Hamada M; Suyama T; Naitoh T; Inoue M; Saitoh T; Uchida Y
Gan To Kagaku Ryoho; 1994 May; 21(6):795-9. PubMed ID: 7514388
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer.
Trevisani L; Putinati S; Sartori S; Abbasciano V; Bagni B
Chest; 1996 Jan; 109(1):104-8. PubMed ID: 8549168
[TBL] [Abstract][Full Text] [Related]
14. CYFRA 21-1 as a tumor marker used in measuring the serum fragment of cytokeratin subunit 19 by immunoradiometric assay.
Sarwar M; Tomiyoshi K; Inoue T; Fukazawa K; Endo K
Ann Nucl Med; 1994 Nov; 8(4):301-6. PubMed ID: 7535552
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of CYFRA assay in diagnosing lung cancer: measurement of serum cytokeratin fragment.
Sugama Y; Kitamura S; Kawai T; Ohkubo A; Hasegawa S; Kuriyama T; Kato H; Fukuoka M; Ohkawa J
Jpn J Cancer Res; 1994 Nov; 85(11):1178-84. PubMed ID: 7530241
[TBL] [Abstract][Full Text] [Related]
16. Assessment of serum CYFRA 21-1 in lung cancer.
Muraki M; Tohda Y; Iwanaga T; Uejima H; Nagasaka Y; Nakajima S
Cancer; 1996 Apr; 77(7):1274-7. PubMed ID: 8608502
[TBL] [Abstract][Full Text] [Related]
17. Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.
Niklinski J; Furman M; Burzykowski T; Chyczewski L; Laudanski J; Chyczewska E; Rapellino M
Br J Cancer; 1996 Sep; 74(6):956-60. PubMed ID: 8826865
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis.
Sumi M; Satoh H; Kagohashi K; Ishikawa H; Sekizawa K
J Clin Lab Anal; 2005; 19(4):146-9. PubMed ID: 16025479
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum and BAL cytokeratin 19 fragment in pulmonary fibrosis and acute interstitial pneumonia.
Dobashi N; Fujita J; Ohtsuki Y; Yamadori I; Yoshinouchi T; Kamei T; Takahara J
Eur Respir J; 1999 Sep; 14(3):574-8. PubMed ID: 10543277
[TBL] [Abstract][Full Text] [Related]
20. Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer.
Chantapet P; Riantawan P; Lebnak P; Getngern P
J Med Assoc Thai; 2000 Apr; 83(4):383-91. PubMed ID: 10808698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
